BioCardia, Inc. (BCDA) Dividend Safety
- Dividend payout ratio · 12 months: Value (m); Formula and calculation Cash dividends paid / net income. Period ending 2026-06-30..
Dividend safety
Overview →Financial period ending 2026-06-30; current quote (m). Amounts retain their stated periods and units.
| Metric | Value | Formula and calculation |
|---|---|---|
| Dividend payout ratio · 12 months | (m) | Cash dividends paid / net income. Period ending 2026-06-30. Calculation unavailable: missing inputs remain (m). |
Calculation inputs
| Input | Amount with unit | Raw financial data |
|---|---|---|
| Dividend payments · 12 months | (m) | |
| Net income · 12 months | -7.34M USD | Net Income (Loss) Attributable to Parent |
Calculated history
Changes compare with the next older row (previous quarter), unless explicitly labeled otherwise. Rolling 12-month growth compares two successive quarter-end rolling totals; it is not year-over-year growth.
| Period ending | Dividend payments · 12 months (USD) | Net income · 12 months (USD) | Dividend payout |
|---|---|---|---|
| 2026-06-30 | (m) | $-7.34M | (m) |
| 2026-03-31 | (m) | $-7.78M | (m) |
| 2025-12-31 | (m) | $-8.23M | (m) |
| 2025-09-30 | (m) | $-8.54M | (m) |
| 2025-06-30 | (m) | $-8.79M | (m) |
| 2025-03-31 | (m) | $-8.39M | (m) |
| 2024-12-31 | (m) | $-7.95M | (m) |
| 2024-09-30 | (m) | $-7.72M | (m) |
| 2024-06-30 | (m) | $-8.56M | (m) |
| 2024-03-31 | (m) | $-10.34M | (m) |
| 2023-12-31 | (m) | $-11.57M | (m) |
| 2023-09-30 | (m) | $-12.53M | (m) |
| 2023-06-30 | (m) | $-13.01M | (m) |
| 2023-03-31 | (m) | $-12.08M | (m) |
| 2022-12-31 | (m) | $-11.91M | (m) |
| 2022-09-30 | (m) | $-12.34M | (m) |
| 2022-06-30 | (m) | $-11.99M | (m) |
| 2022-03-31 | (m) | $-12.98M | (m) |
| 2021-12-31 | (m) | $-12.62M | (m) |
| 2021-09-30 | (m) | $-12.15M | (m) |
| 2021-06-30 | (m) | $-13.29M | (m) |
| 2021-03-31 | (m) | $-13.38M | (m) |
| 2020-12-31 | (m) | $-15.00M | (m) |
| 2020-09-30 | (m) | $-15.52M | (m) |
| 2020-06-30 | (m) | $-15.46M | (m) |
| 2020-03-31 | (m) | $-15.64M | (m) |
| 2019-12-31 | (m) | $-14.71M | (m) |
| 2019-09-30 | (m) | $-14.85M | (m) |
| 2019-06-30 | (m) | $-14.60M | (m) |
| 2019-03-31 | (m) | $-14.07M | (m) |
| 2018-12-31 | (m) | $-13.99M | (m) |
| 2018-09-30 | (m) | $-13.83M | (m) |
| 2018-06-30 | (m) | $-13.29M | (m) |
| 2018-03-31 | (m) | $-13.02M | (m) |
| 2017-12-31 | (m) | $-12.31M | (m) |
| 2017-09-30 | (m) | $-12.40M | (m) |
| 2017-06-30 | (m) | $-12.66M | (m) |
| 2017-03-31 | (m) | $-11.69M | (m) |
| 2016-12-31 | (m) | $-10.31M | (m) |
| 2016-09-30 | (m) | $5.37M | (m) |
| 2016-06-30 | (m) | $330.00K | (m) |
| 2016-03-31 | (m) | $328.00K | (m) |
| 2015-12-31 | (m) | $322.00K | (m) |
| 2015-09-30 | (m) | $293.00K | (m) |
| 2015-06-30 | (m) | $253.00K | (m) |
| 2015-03-31 | (m) | $246.00K | (m) |
| 2014-12-31 | (m) | $234.00K | (m) |
| 2014-09-30 | (m) | $178.00K | (m) |
| 2014-06-30 | (m) | $165.00K | (m) |
| 2014-03-31 | (m) | $108.00K | (m) |
| 2013-12-31 | (m) | $19.00K | (m) |
| 2013-09-30 | (m) | $52.00K | (m) |
| 2013-06-30 | (m) | $473.00K | (m) |
| 2013-03-31 | (m) | $335.00K | (m) |
| 2012-12-31 | (m) | $305.00K | (m) |
| 2012-09-30 | (m) | $-18.00K | (m) |
| 2012-06-30 | (m) | $-1.04M | (m) |
| 2012-03-31 | (m) | $9.93M | (m) |
| 2011-12-31 | (m) | $9.66M | (m) |
| 2011-09-30 | (m) | (m) | (m) |
| 2011-06-30 | (m) | (m) | (m) |
| 2011-03-31 | (m) | (m) | (m) |
| 2010-12-31 | (m) | $-11.51M | (m) |
| 2010-09-30 | (m) | (m) | (m) |
| 2010-06-30 | (m) | (m) | (m) |
(m) means missing inputs. Historical market-based ratios use the saved close on or immediately before period ending and that period’s reported shares; current quotes are not substituted. Five-year projections repeat historical CAGR, not analyst forecasts.
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| DYADIC INTERNATIONAL INC (DYAI) | United States | $0.016B | |
| Passage BIO, Inc. (PASG) | United States | $0.015B | -0.43 |
| Pluri Inc. (PLUR) | $0.014B | ||
| INTENSITY THERAPEUTICS, INC. (INTS) | United States | $0.013B | -1.08 |
| BRAINSTORM CELL THERAPEUTICS INC. (BCLI) | United States | $0.013B | -1.05 |
| Jasper Therapeutics, Inc. (JSPR) | United States | $0.020B | -0.37 |
| Estrella Immunopharma, Inc. (ESLA) | United States | $0.020B | |
| IN8BIO, INC. (INAB) | United States | $0.012B | -0.76 |
| Senti Biosciences Holdings, Inc. (SNTI) | United States | $0.011B | -0.70 |
| TScan Therapeutics, Inc. (TCRX) | United States | $0.008B | -1.23 |